Advertisement
MD vs THC
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MD is a Buy and THC is a Buy.
MD's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for MD turned positive on October 08, 2026. Looking at past instances where MD's MACD turned positive, the stock continued to rise in 35 of 45 cases over the following month. The odds of a continued upward trend are 78%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on MD as a result. In 71 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.
MD moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MD crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 61%.
Following a +5.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where MD advanced for three days, in 193 of 297 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
The Aroon Indicator entered an Uptrend today. In 134 of 198 cases where MD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 68%.
Bearish Trend Analysis
The 10-day RSI Indicator for MD moved out of overbought territory on November 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In 23 of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at 85%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 42 of 59 cases where MD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 71%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
MD broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. MD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 46 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 60 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.886) is normal, around the industry mean (204.532). P/E Ratio (14.690) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.120) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (1.119) is also within normal values, averaging (2.688).
The Tickeron Profit vs. Risk Rating rating for this company is 83 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
Momentum Indicator for THC turns positive, indicating new upward trend
THC saw its Momentum Indicator move above the 0 level on November 04, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 79 similar instances where the indicator turned positive. In 67 of the 79 cases, the stock moved higher in the following days. The odds of a move higher are at 85%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for THC just turned positive on November 04, 2026. Looking at past instances where THC's MACD turned positive, the stock continued to rise in 36 of 44 cases over the following month. The odds of a continued upward trend are 82%.
THC moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for THC crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
Following a +1.77% 3-day Advance, the price is estimated to grow further. Considering data from situations where THC advanced for three days, in 262 of 321 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 222 of 264 cases where THC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 84%.
Bearish Trend Analysis
The 10-day RSI Indicator for THC moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 54 similar instances where the indicator moved out of overbought territory. In 32 of the 54 cases, the stock moved lower in the following days. This puts the odds of a move lower at 59%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where THC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
THC broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 10 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.
The Tickeron SMR rating for this company is 20 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. THC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 69 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.898) is normal, around the industry mean (204.532). P/E Ratio (10.872) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (1.789) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (1.022) is also within normal values, averaging (2.688).
The Tickeron PE Growth Rating for this company is 75 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
MD | THC | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 60 Fair valued | 69 Overvalued | |
PROFIT vs RISK RATING 1..100 | 83 | 10 | |
SMR RATING 1..100 | 46 | 20 | |
PRICE GROWTH RATING 1..100 | 37 | 38 | |
P/E GROWTH RATING 1..100 | 17 | 75 | |
SEASONALITY SCORE 1..100 | 3 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MD's Valuation (60) in the Medical Or Nursing Services industry is in the same range as THC (69) in the Hospital Or Nursing Management industry. This means that MD’s stock grew similarly to THC’s over the last 12 months.
THC's Profit vs Risk Rating (10) in the Hospital Or Nursing Management industry is significantly better than the same rating for MD (83) in the Medical Or Nursing Services industry. This means that THC’s stock grew significantly faster than MD’s over the last 12 months.
THC's SMR Rating (20) in the Hospital Or Nursing Management industry is in the same range as MD (46) in the Medical Or Nursing Services industry. This means that THC’s stock grew similarly to MD’s over the last 12 months.
MD's Price Growth Rating (37) in the Medical Or Nursing Services industry is in the same range as THC (38) in the Hospital Or Nursing Management industry. This means that MD’s stock grew similarly to THC’s over the last 12 months.
MD's P/E Growth Rating (17) in the Medical Or Nursing Services industry is somewhat better than the same rating for THC (75) in the Hospital Or Nursing Management industry. This means that MD’s stock grew somewhat faster than THC’s over the last 12 months.
| MD | THC | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 85% | 4 days ago 59% |
| Stochastic ODDS (%) | 4 days ago 71% | 4 days ago 65% |
| Momentum ODDS (%) | 4 days ago 74% | 4 days ago 85% |
| MACD ODDS (%) | 4 days ago 78% | 4 days ago 82% |
| TrendWeek ODDS (%) | 4 days ago 65% | 4 days ago 80% |
| TrendMonth ODDS (%) | 4 days ago 65% | 4 days ago 78% |
| Advances ODDS (%) | 8 days ago 65% | 11 days ago 82% |
| Declines ODDS (%) | 4 days ago 70% | 4 days ago 66% |
| BollingerBands ODDS (%) | 4 days ago 76% | 4 days ago 56% |
| Aroon ODDS (%) | 4 days ago 68% | 4 days ago 84% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MD’s FA Score shows that 1 FA rating(s) are green while THC’s FA Score has 2 green FA rating(s).
- MD’s FA Score: 1 green, 4 red.
- THC’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MD’s TA Score shows that 6 TA indicator(s) are bullish while THC’s TA Score has 6 bullish TA indicator(s).
- MD’s TA Score: 6 bullish, 4 bearish.
- THC’s TA Score: 6 bullish, 4 bearish.
Price Growth
MD (@Hospital/Nursing Management) experienced а +4.93% price change this week, while THC (@Hospital/Nursing Management) price change was +3.69% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -2.34%. For the same industry, the average monthly price growth was +2.28%, and the average quarterly price growth was +11.65%.
Reported Earning Dates
MD is expected to report earnings on Feb 18, 2027.
THC is expected to report earnings on Feb 11, 2027.
Industries' Descriptions
@Hospital/Nursing Management (-2.34% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
Advertisement
MD and
Correlation & Price change
A.I.dvisor indicates that over the last year, MD has been loosely correlated with UHS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if MD jumps, then UHS could also see price increases.
THC and
Correlation & Price change
A.I.dvisor indicates that over the last year, THC has been loosely correlated with HCA. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if THC jumps, then HCA could also see price increases.